Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Express Scripts
Medtronic
Baxter
Johnson and Johnson
Dow

Last Updated: December 7, 2021

Volunteer for clinical trials for gabapentin enacarbil at ClinicalTrialExchange

DrugPatentWatch Database Preview

Gabapentin enacarbil - Generic Drug Details

➤ Subscribe for complete access

« Back to Dashboard

What are the generic drug sources for gabapentin enacarbil and what is the scope of patent protection?

Gabapentin enacarbil is the generic ingredient in one branded drug marketed by Arbor Pharms Llc and is included in one NDA. There are six patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Gabapentin enacarbil has one hundred and forty-eight patent family members in twenty-six countries.

There are twenty-nine drug master file entries for gabapentin enacarbil. One supplier is listed for this compound.

Summary for gabapentin enacarbil
International Patents:148
US Patents:6
Tradenames:1
Applicants:1
NDAs:1
Drug Master File Entries: 29
Finished Product Suppliers / Packagers: 1
Raw Ingredient (Bulk) Api Vendors: 50
Clinical Trials: 28
Patent Applications: 513
Formulation / Manufacturing:see details
What excipients (inactive ingredients) are in gabapentin enacarbil?gabapentin enacarbil excipients list
DailyMed Link:gabapentin enacarbil at DailyMed
Recent Clinical Trials for gabapentin enacarbil

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of Texas at AustinPhase 4
National Institute on Aging (NIA)Phase 4
University of Missouri-ColumbiaN/A

See all gabapentin enacarbil clinical trials

Pharmacology for gabapentin enacarbil
Anatomical Therapeutic Chemical (ATC) Classes for gabapentin enacarbil
Paragraph IV (Patent) Challenges for GABAPENTIN ENACARBIL
Tradename Dosage Ingredient NDA Submissiondate
HORIZANT TABLET, EXTENDED RELEASE;ORAL gabapentin enacarbil 022399 2019-04-29

US Patents and Regulatory Information for gabapentin enacarbil

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Arbor Pharms Llc HORIZANT gabapentin enacarbil TABLET, EXTENDED RELEASE;ORAL 022399-001 Apr 6, 2011 RX Yes Yes ⤷  Try it Free ⤷  Try it Free Y ⤷  Try it Free
Arbor Pharms Llc HORIZANT gabapentin enacarbil TABLET, EXTENDED RELEASE;ORAL 022399-001 Apr 6, 2011 RX Yes Yes ⤷  Try it Free ⤷  Try it Free Y Y ⤷  Try it Free
Arbor Pharms Llc HORIZANT gabapentin enacarbil TABLET, EXTENDED RELEASE;ORAL 022399-002 Dec 13, 2011 RX Yes No ⤷  Try it Free ⤷  Try it Free Y Y ⤷  Try it Free
Arbor Pharms Llc HORIZANT gabapentin enacarbil TABLET, EXTENDED RELEASE;ORAL 022399-002 Dec 13, 2011 RX Yes No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Arbor Pharms Llc HORIZANT gabapentin enacarbil TABLET, EXTENDED RELEASE;ORAL 022399-002 Dec 13, 2011 RX Yes No ⤷  Try it Free ⤷  Try it Free Y Y ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Colorcon
Dow
Merck
Johnson and Johnson
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.